Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

Central Drugs Standard Control Organisation (CDSCO) on Friday released the list of Not of Standard Quality (NSQ) and Spurious ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Medicare plans have a list of medications, both brand-name and generic, they cover. This list is called a formulary. You can use it when comparing plans. Share on Pinterest alvarez/Getty Images ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...